Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
Top Cited Papers
- 30 June 2011
- journal article
- review article
- Published by Elsevier BV in Drug Resistance Updates
- Vol. 14 (3), 191-201
- https://doi.org/10.1016/j.drup.2011.03.001
Abstract
No abstract availableKeywords
This publication has 147 references indexed in Scilit:
- HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinaseNature, 2010
- Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cellsZeitschrift für Krebsforschung und Klinische Onkologie, 2010
- HIF-1: upstream and downstream of cancer metabolismCurrent Opinion in Genetics & Development, 2010
- Targeting the hypoxia-inducible factor (HIF) pathway in cancerExpert Reviews in Molecular Medicine, 2009
- Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapiesDrug Resistance Updates, 2009
- HIF‐1α and HIF‐2α have divergent roles in colon cancerInternational Journal of Cancer, 2008
- Living on a break: cellular senescence as a DNA-damage responseNature Reviews Cancer, 2008
- No death without life: vital functions of apoptotic effectorsCell Death & Differentiation, 2008
- Autophagy fights disease through cellular self-digestionNature, 2008
- RACK1 Competes with HSP90 for Binding to HIF-1α and Is Required for O2-Independent and HSP90 Inhibitor-Induced Degradation of HIF-1αMolecular Cell, 2007